Cargando…
Critical role for Sec22b-dependent antigen cross-presentation in antitumor immunity
CD8(+) T cells mediate antigen-specific immune responses that can induce rejection of solid tumors. In this process, dendritic cells (DCs) are thought to take up tumor antigens, which are processed into peptides and loaded onto MHC-I molecules, a process called “cross-presentation.” Neither the actu...
Autores principales: | Alloatti, Andrés, Rookhuizen, Derek C., Joannas, Leonel, Carpier, Jean-Marie, Iborra, Salvador, Magalhaes, Joao G., Yatim, Nader, Kozik, Patrycja, Sancho, David, Albert, Matthew L., Amigorena, Sebastian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5551575/ https://www.ncbi.nlm.nih.gov/pubmed/28663435 http://dx.doi.org/10.1084/jem.20170229 |
Ejemplares similares
-
Correction: Critical role for Sec22b-dependent antigen cross-presentation in antitumor immunity
por: Alloatti, Andrés, et al.
Publicado: (2018) -
Small Molecule Enhancers of Endosome-to-Cytosol Import Augment Anti-tumor Immunity
por: Kozik, Patrycja, et al.
Publicado: (2020) -
Sec22b-dependent antigen cross-presentation is a significant contributor of T cell priming during infection with the parasite Trypanosoma cruzi
por: Biscari, Lucía, et al.
Publicado: (2023) -
Dendritic cell maturation and cross‐presentation: timing matters!
por: Alloatti, Andrés, et al.
Publicado: (2016) -
Endocytic membrane repair by ESCRT-III controls antigen export to the cytosol during antigen cross-presentation
por: Gros, Marine, et al.
Publicado: (2022)